HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan C Bird Selected Research

Telangiectasis (Telangiectasia)

1/2021Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression.
1/2018Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.
1/2018ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
1/2018CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
4/2015Multimodal imaging in type 2 idiopathic macular telangiectasia.
4/2015Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.
7/2013Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?
5/2013Macular telangiectasia type 2.
9/2012Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
12/2011Retinal crystals in type 2 idiopathic macular telangiectasia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alan C Bird Research Topics

Disease

19Macular Degeneration (Age-Related Maculopathy)
01/2020 - 03/2002
11Telangiectasis (Telangiectasia)
01/2021 - 03/2008
6Atrophy
01/2020 - 07/2004
6Choroidal Neovascularization
02/2012 - 03/2004
4Disease Progression
01/2018 - 07/2005
4Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2007 - 01/2002
2Retinal Degeneration
01/2007 - 01/2004
1Type 2 Diabetes Mellitus (MODY)
01/2021
1COVID-19
01/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2018
1Dementia (Dementias)
10/2011
1Hypertension (High Blood Pressure)
12/2010
1Retinal Diseases
03/2008
1Retinal Dystrophies
03/2008
1Hearing Loss (Hearing Impairment)
03/2008
1Vision Disorders (Hemeralopia)
09/2007
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
09/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2007
1Blindness (Hysterical Blindness)
04/2007
1Cone Dystrophy
09/2006
1Geographic Atrophy
02/2006
1Hemoglobin SC Disease (Disease, Hemoglobin SC)
11/2005
1Deafness (Deaf Mutism)
07/2004
1Noninsulin-dependent diabetes mellitus with deafness
07/2004
1Leber Congenital Amaurosis
07/2004
1Mydriasis
01/2004
1congenital stationary Night blindness
02/2003
1Refsum Disease (Refsum's Disease)
01/2003

Drug/Important Bio-Agent (IBA)

22Retinaldehyde (Retinal)IBA
01/2021 - 01/2003
4Retinal Pigments (Pigments, Visual)IBA
01/2020 - 03/2004
3Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2005
3Fluorescein (Funduscein)FDA LinkGeneric
04/2015 - 11/2005
3Proteins (Proteins, Gene)FDA Link
02/2015 - 04/2002
3Macular PigmentIBA
05/2013 - 12/2010
3AntibodiesIBA
10/2012 - 07/2005
3Complement Factor H (Factor H)IBA
09/2012 - 02/2006
2Serine (L-Serine)FDA Link
01/2021 - 09/2012
2ZincIBA
01/2020 - 04/2007
2Ciliary Neurotrophic Factor (CNTF)IBA
01/2018 - 04/2015
2Complement C3 (C3 Complement)IBA
09/2012 - 08/2007
2LipofuscinIBA
03/2008 - 12/2006
2RNA Splicing FactorsIBA
03/2007 - 01/2002
2RNA Precursors (Precursor, mRNA)IBA
03/2007 - 01/2002
2Messenger RNA (mRNA)IBA
11/2003 - 10/2003
1Hormones (Hormone)IBA
01/2018
1Estrogens (Estrogen)FDA Link
01/2018
1TamoxifenFDA LinkGeneric
01/2018
1LipidsIBA
02/2015
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
07/2013
1LuteinIBA
05/2013
1ZeaxanthinsIBA
05/2013
1chemotactic factor inactivatorIBA
09/2012
1Complement C2 (Complement Component 2)IBA
09/2012
1Lipase (Acid Lipase)FDA Link
09/2012
1Peptide Hydrolases (Proteases)FDA Link
09/2012
1Complement Factor B (Factor B)IBA
09/2012
1Immunoglobulin M (IgM)IBA
02/2012
1AutoantibodiesIBA
02/2012
1Immunoglobulin G (IgG)IBA
02/2012
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2010
1Mitochondrial DNA (mtDNA)IBA
03/2008
1Complement System Proteins (Complement)IBA
08/2007
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
09/2006
1Sickle HemoglobinIBA
11/2005
1aryl hydrocarbon receptor-interacting proteinIBA
07/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2004
1Tissue Inhibitor of Metalloproteinase-3IBA
11/2003
1Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
04/2002

Therapy/Procedure

4Therapeutics
01/2018 - 01/2004
3Lasers (Laser)
03/2008 - 03/2002
1Intravitreal Injections
01/2007